The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
October 8th 2024
An interim analysis of the PRO-SPIRIT study compared outcomes at 3 months after starting new treatments for psoriatic arthritis.
Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
October 26, 2024
Register Now!
6th Annual Advanced Practice Collaborative
View More
SimulatED™: Personalizing Treatment Choices to Achieve Glycemic and Weight Management Goals
View More
Cases and Conversations™: Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
November 18, 2024
Register Now!
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
SLE Patients Stake a Claim on Hydroxychloroquine
March 27th 2020Patients with systemic lupus erythematosus depend on hydroxychloroquine to control disease activity, but demand for this drug, which was already in short supply, has spiked since President Trump championed its use for COVID-19 patients. The American College of Rheumatology has responded by issuing a series of recommendations. Learn more in this article.
Colchicine for Gout Gets a Clean Bill of Health
March 26th 2020Colchicine, a first-line treatment option for acute gout, is associated with an increased risk of adverse events, such as diarrhea and other gastrointestinal symptoms, but not serious adverse events, finds a newly published systematic review and meta-analysis.
Abatacept Fails Clinical Trial for Sjögren’s Syndrome
March 24th 2020The use of abatacept did not lead to significant improvements in the disease status of patients with primary Sjögren's syndrome and in fact, it was essentially no better than placebo treatment, shows the first randomized, double-blind trial on abatacept for Sjögren’s.
Study Questions Value of Plasma Exchange for Vasculitis
March 24th 2020Despite the publication of previous clinical trials that showed plasma exchange could possibly be a viable treatment for patients with severe ANCA-associated vasculitis, a new study recently published in the New England Journal of Medicine shows the treatment, in combination with standard therapy, didn't improve outcomes for patients or lower fatality rates or slow the progression to end-stage kidney disease.
Ibuprofen Covid-19 Warning May Be Premature
March 19th 2020On Tuesday, the World Health Organization announced it is recommending that people with COVID-19 symptoms avoid taking the anti-inflammatory drug ibuprofen. U.S. officials and physicians responded with skepticism and today, WHO reversed its decision.
COVID-19 Rheumatology Registry Underway
March 19th 2020Dr. Philip Robinson, a rheumatologist in Brisbane, Australia, is in the process of creating an international registry that will include information about COVID-19 specifically for patients with rheumatic disease, in particular, those receiving immunosuppressive therapies.
Important Conversations: Anxiety Management and Wellness
March 18th 2020As coronavirus moves its way across the country, Dr. Kim Gorgens, a psychologist with more than 20 years of experience, recommends that rheumatologists proactively reach out to their patients to address concerns that may lead to stress and ill-advised changes in treatment regimens, such as stopping treatments without consulting a physician.
Febuxostat Hypersensitivity Risk in Gout Similar to Allopurinol
March 17th 2020A new study published in the February 5 issue of Annals of the Rheumatic Diseases finds that allopurinol and febuxostat are associated with about the same risk of hypersensitivity reactions, as compared to gout patients treated with colchicine. The risk is even higher for women and diabetes patients, the authors wrote.
Women's History Month: Q&A with Rheumatologist Silvia Ross, M.D.
March 12th 2020To celebrate Women’s History Month, we’re featuring important female figures in rheumatology. In this Q&A with Silvia Ross, M.D., F.A.C.R., managing partner of Triangle Arthritis & Rheumatology Associates, Raleigh, North Carolina, and co-chair of Global Affairs for the Association of Women in Rheumatology, we focus on her work history, her accomplishments, and her future.
FDA Approves New Treatment for Chronic Fibrosing ILD
March 10th 2020The U.S. Food and Drug Administration has approved the first-ever treatment for chronic fibrosing interstitial lung disease (ILD), a condition that can affect rheumatoid arthritis patients. The treatment is designed for patients with a form of the disease that progressively worsens over time.
RA Quiz: Can you identify early rheumatoid arthritis?
March 10th 2020Early rheumatoid arthritis is, in part, defined as having symptoms for at least six months. Beyond six months, it's considered established rheumatoid arthritis. But diagnosing early rheumatoid arthritis is not that straightforward. Serologic tests can confirm a clinical diagnosis, but these tests aren't always reliable and can be negative in about 50 percent of rheumatoid arthritis cases. In this quiz, we focus on the diagnosis and treatment of early rheumatiod arthritis.
News Roundup: Coronavirus and Autoimmune Disease
March 6th 2020What is the connection (if any) between coronavirus and autoimmune diseases? In this slideshow, we feature some points of view from rheumatology experts in the field, including Dr. Jean Liew of the University in Washington, Seattle, who told CreakyJoints that patients with inflammatory arthritis are probably more susceptible to the coronavirus and are at higher risk of complications like pneumonia.
Prime-Boost Bests a Single Pneumococcal Vaccination in Patients Receiving DMARDs
March 5th 2020A two-pronged vaccination approach performs better than a single pneumococcal vaccination in patients receiving conventional DMARDs or abatacept-treated patients, but not in patients receiving rituximab, say researchers writing in Arthritis Research & Therapy.
Hip Fracture Risk Increases with Tramadol
March 5th 2020The use of tramadol in older patients is associated with a higher risk of hip fracture compared with the use of codeine or commonly used nonsteroidal anti-inflammatory drugs (NSAIDs), say researchers recently writing in in the Journal of Bone and Mineral Research.
Complications from Hip Replacement Surgery Are Extensive for Kidney Patients
March 5th 2020Hip replacements may not be the best choice for acute kidney injury patients, shows a new study that highlights above normal rates of death, longer hospital stays, revisions, transfusions, implant problems, above norm hospital charges; and, discharge to rehab hospitals.
Tocilizumab May Help Uveitis in Juvenile Idiopathic Arthritis
March 3rd 2020Tocilizumab might be a useful adjunctive therapeutic option for children with juvenile idiopathic arthritis-associated uveitis that doesn't respond to TNFi treatment, say researchers recently writing in The Lancet Rheumatology.
Methotrexate Lowers Immunogenicity to Adalimumab in Axial Spondyloarthritis
February 29th 2020Adding methotrexate to adalimumab (Humira, AbbVie) in axial spondyloarthritis was associated with reduced immunogenicity, and prolonged co-medication was associated with long-term maintenance of adalimumab, say researchers recently writing in RMD Open: Rheumatic & Musculoskeletal Diseases.